Schrödinger said it is ending development of the CHC7 inhibitor in blood cancer as both a monotherapy and combination.

Remegen's Telitacicept met its primary endpoints in a Chinese trial, while a US-based Phase III trial in Sjögren's syndrome ...

Aligos has initiated dosing in the Phase II B-SUPREME trial of its ALG-000184 in people with chronic hepatitis B virus (HBV) ...

CuraCell Holding’s CTA has received approval from Germany's Paul-Ehrlich-Institut (PEI) to begin a Phase I/IIa trial of CC-38 ...

Vendanta's CEO also announced the company is cutting 20% of its workforce as a result of the Phase II UC trial failure.

Patient demonstrations, ongoing clinical trials and heavy investment signal that BCIs could be commercialised by 2030.

The close relationship between gastroparesis and diabetes makes this condition a significant public health concern.